Does tiotropium lower exacerbation and hospitalization frequency in COPD patients: results of a meta-analysis
暂无分享,去创建一个
[1] N. Chavannes,et al. Exacerbations and associated healthcare cost in patients with COPD in general practice. , 2016, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.
[2] M. Decramer,et al. Tiotropium HandiHaler® in the treatment of COPD: A safety review , 2009, International journal of chronic obstructive pulmonary disease.
[3] Lucas M Bachmann,et al. Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis , 2009, BMC Medicine.
[4] M. Decramer,et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. , 2008, The New England journal of medicine.
[5] T. Perez,et al. Effect of tiotropium on health-related quality of life as a primary efficacy endpoint in COPD , 2008, International journal of chronic obstructive pulmonary disease.
[6] L. Nannini,et al. Tiotropium for the treatment of stable chronic obstructive pulmonary disease: a systematic review with meta-analysis. , 2007, Pulmonary pharmacology & therapeutics.
[7] G. Donaldson,et al. Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD , 2007, European Respiratory Journal.
[8] D. Price,et al. Efficacy and safety of tiotropium in COPD patients in primary care – the SPiRiva Usual CarE (SPRUCE) study , 2007, Respiratory research.
[9] C. Wentworth,et al. Pooled clinical trial analysis of tiotropium safety. , 2006, Chest.
[10] J. Bourbeau,et al. Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis , 2006, Thorax.
[11] D. Dusser,et al. The effect of tiotropium on exacerbations and airflow in patients with COPD. , 2006, The European respiratory journal.
[12] D. D. Briggs,et al. Improved daytime spirometric efficacy of tiotropium compared with salmeterol in patients with COPD. , 2005, Pulmonary pharmacology & therapeutics.
[13] D. Niewoehner,et al. Prevention of Exacerbations of Chronic Obstructive Pulmonary Disease with Tiotropium, a Once-Daily Inhaled Anticholinergic Bronchodilator , 2005, Annals of Internal Medicine.
[14] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[15] V. Brusasco,et al. Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. , 2003, Thorax.
[16] R. Zuwallack,et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease , 2002, European Respiratory Journal.
[17] J. V. van Noord,et al. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium , 2002, European Respiratory Journal.
[18] J. Bourbeau,et al. Inhaled tiotropium for stable chronic obstructive pulmonary disease. , 2000, The Cochrane database of systematic reviews.
[19] C. Begg,et al. Publication bias and dissemination of clinical research. , 1989, Journal of the National Cancer Institute.
[20] T. Seemungal,et al. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. , 2008, American journal of respiratory and critical care medicine.
[21] H. Magnussen,et al. Improvements with tiotropium in COPD patients with concomitant asthma. , 2008, Respiratory medicine.
[22] F. Maltais,et al. A randomized controlled trial to assess the efficacy of tiotropium in Canadian patients with chronic obstructive pulmonary disease. , 2007, Canadian respiratory journal.
[23] P. Calverley,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.
[24] C. Lenfant,et al. Global Initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease , 2006 .
[25] V. Brusasco,et al. Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD. , 2003, Thorax.